Patents by Inventor Marc R. Paquin

Marc R. Paquin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6699484
    Abstract: An especially useful fibrin glue composition comprises a biocompatible, bioabsorbable hyaluronic acid derivative material, upon which are applied or chemically bonded fibrinogen and thrombin, along with other optional constituents, such as additional coagulation factors, anti-fibrinolytics, stabilizers and biologically active substances. The fibrinogen, thrombin and other components can take the form of a dry preparation, an aqueous or nonaqueous preparation, or as a combination thereof. Such a fibrin glue composition can be placed directly on a wound site and is fully reabsorbed into the body.
    Type: Grant
    Filed: January 6, 2003
    Date of Patent: March 2, 2004
    Assignee: Haemacure Corporation
    Inventors: Elaine Whitmore, Marc R. Paquin
  • Publication number: 20030103961
    Abstract: An especially useful fibrin glue composition comprises a biocompatible, bioabsorbable hyaluronic acid derivative material, upon which are applied or chemically bonded fibrinogen and thrombin, along with other optional constituents, such as additional coagulation factors, anti-fibrinolytics, stabilizers and biologically active substances. The fibrinogen, thrombin and other components can take the form of a dry preparation, an aqueous or nonaqueous preparation, or as a combination thereof. Such a fibrin glue composition can be placed directly on a wound site and is fully reabsorbed into the body.
    Type: Application
    Filed: January 6, 2003
    Publication date: June 5, 2003
    Applicant: Haemacure Corporation
    Inventors: Elaine Whitmore, Marc R. Paquin
  • Patent number: 6503527
    Abstract: A fibrin adhesive or sealant composition comprising a biocompatible, bioabsorbable hyaluronic acid material, chitin material, or chitosan material to which fibrinogen and a fibrinogen-cleaving agent are applied, along with other components such as additional coagulation factors, anti-fibrinolytics, stabilizers and biologically active substances. The fibrinogen, fibrinogen-cleaving agent and other components can take the form of dry preparation, an aqueous or nonaqueous preparation, or a combination thereof. Such a composition can be placed directly on, around, or within a wound site and is fully reabsorbed into the body.
    Type: Grant
    Filed: August 14, 2000
    Date of Patent: January 7, 2003
    Assignee: Haemacure Corporation
    Inventors: Elaine Whitmore, Marc R. Paquin